A-Alpha Bio
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2017
- Type
- Corporation Seattle business license
- Employees
- 50
- Registered name
- A Alpha Bio Inc Seattle business license
- Stage
- startup
- Total raised
- $23.1M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $20.3M · Aug 2021 SEC Form D
- Founders
- David Younger, PhD, Randolph Lopez, PhD
Harell Data founded by Harlan Robins raises $15M to let data owners securely monetize AI training
Harlan Robins, co-founder and former CSO of Adaptive Biotechnologies, launched Harell Data with $15 million in funding to let proprietary data owners securely host datasets for AI model training and receive direct revenue shares instead of waiting for downstream royalties.
Seattle Startups Yoodli and A-Alpha Bio Appoint New C-Suite Execs, TiE Seattle Names Siddhartha Srinivasa as President
Seattle startups Yoodli, A-Alpha Bio, and MoxiWorks have added senior executives, including Andy Larson as Yoodli's CFO and Troy Lionberger as A-Alpha Bio's chief business officer, while TiE Seattle appointed Siddhartha Srinivasa as president. These moves highlight growth and leadership shifts in the Seattle tech sector, with companies focusing on AI, biotech, and robotics.
Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model
Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.
People
-
David Younger Founder, Co-Founder and CEO, Executive Officer, Director
-
Randolph Lopez Founder, Co-founder & CTO
-
Matt McIlwain Director, Board Member
